FDA
CRN Asks FDA: “Remove Impasses to Longstanding Issues; Promote Innovation by Protecting Intellectual Property”
College Park, MD—On May 16, FDA held a public meeting titled “Responsible Innovation in Dietary Supplements.” The meeting was intended to give interested parties...
Congress Urges FDA To Move Forward With CBD Legalization
Washington, D.C.—Senator Ron Wyden (D-OR) urged FDA to promptly issue guidance that ensures the regulatory pathway Congress intended for the lawful use of CBD...
FDA Issues Warning Letters to Two Companies Selling Kratom
Silver Spring, MD—FDA issued warning letters to Cali Botanicals of Folsom, CA, and Kratom NC of Wilmington, NC, for illegally selling unapproved misbranded kratom-containing...
FDA Announces Qualified Health Claims for EPA, DHA
Silver Spring, MD—FDA announced in a press release that it “does not intend to object” to the use of qualified health claims stating that...
House Passes Amendment Designed to Ensure CBD is Regulated by FDA
Washington, DC--The Natural Products Association (NPA) announced earlier this week that it was seeking help from Congress to encourage the Food and Drug Administration...
CRN on DSHEA at 25: The Industry is at a Crossroads
New York, NY—Day one of the 7th Annual Legal, Regulatory and Compliance Forum on Dietary Supplements by the American Conference Institute (ACI) together with...
FDA Warns Women Against Vinpocetine; NPA Alleges “Red Herring”
Washington, D.C.—FDA issued a statement warning women of childbearing age about use of vinpocetine, due to a recent report from the National Institute of...
Fruit Purees Sweeten Without “Added Sugar” Count
Fruit purees could be a viable solution for food companies looking to avoid added sugars, according to a press release from Welch’s.
Given the FDA’s...
FDA Cannabis/CBD Public Hearing: “FDA Does Not Have the Luxury Of Time”
Washington, D.C.—The Food and Drug Administration (FDA) held a public hearing on Friday looking for scientific data and information regarding cannabis and cannabis-derived compounds....
May 31 CBD Hearing to Focus on Legalization, Regulation
Washington, D.C.—Tomorrow, from 8:00 AM EDT to 6:00 PM EDT, FDA will hold a public hearing—to be webcast, here and here—entitled “Scientific Data and...
